ASHP Accredited
Program Director: Matt Whiteman, PharmD, BCPPS
Positions: 7
Application Due: TBD
Starting Date: TBD
Estimated Stipend: $53,000 + benefits
Purpose Statement
PGY1 residency programs build upon Doctor of Pharmacy (PharmD) education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competencies, goals, and objectives. Residents who successfully complete PGY1 residency programs will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) pharmacy residency training.
Program Overview
PGY1 Residents at WVU Hospitals will be provided the opportunity to accelerate their growth beyond entry-level professional competence in patient-centered care and in pharmacy operational services, and to further the development of leadership skills that can be applied in any position and in any practice setting. PGY1 Residents will acquire substantial knowledge required for skillful problem solving, refine their problem-solving strategies, strengthen their professional values and attitudes, and advance the growth of their clinical judgment. The instructional emphasis is on the progressive development of clinical judgment, a process begun in the advanced pharmacy practice experiences (APPE) of the professional school years but requiring further extensive practice, self-reflection, and shaping of decision-making skills fostered by feedback on performance. Their residency year provides a fertile environment for accelerating growth beyond entry-level professional competence through supervised practice under the guidance of model practitioners. Residents will exhibit a commitment to the profession of pharmacy and be able to develop their own personal plan for professional development. Residents completing this program will have the knowledge, skills, and abilities that are highly marketable.
The program is a twelve-month, postgraduate training experience composed of six major elements:
- Inpatient Care
- Ambulatory Patient Care
- Medication Management
- Practice Management
- Practice-Related Education/Training
- Practice-Related Research
The program varies for each resident based upon his or her goals, interests, and previous experiences. In accordance with current ASHP standards, all residents are required to complete learning experiences in core subject areas considered to be essential to the practice of pharmacy. Additional requirements include the development and completion of practice-related research, the development of oral/written communication skills, the completion of a Medication Use Evaluation, the presentation of ACPE Accredited Continuing Education seminars, the participation in various hospital committees, operational practice, and teaching components. Elective learning experiences are available to permit the resident flexibility in pursuing individual goals. Upon successful completion of the requirements, PGY1 Residents are awarded a residency certificate.
PGY1 Learning Experiences
The program consists of required elective block and longitudinal rotations. The block rotations are generally five weeks in duration, and the elective rotations are based on the resident’s professional interests.
Required Rotational Experiences:
- Orientation
- Internal Medicine
Selective Rotational Experiences:
- Critical Care: Resident selects one of the following
- Cardiovascular Intensive Care (CVICU)
- Medical Intensive Care (MICU)
- Neurocritical Care (NCCU)
- Surgical Intensive Care (SICU)
- Ambulatory Care: Resident selects one of the following
- Cardiology
- Heart Failure/Pulmonary Hypertension
- Endocrinology
- Family Medicine
- Gastroenterology
- Neurology
- Rheumatology
- Specialty Pharmacy
- Transitions of Care
- Weight Management
-
Practice Management: Resident selects one of the following
- Clinical
- Education
- Operations
- Retail
- Specialty
- Supply Chain
-
Pediatrics or Oncology: Resident selects one of the following
- Stem Cell Transplant/Hematologic Malignancies
- General Pediatrics
- Pediatric Intensive Care
- Neonatal Intensive Care
- Inpatient Adult or Pediatric Oncology
- Outpatient Adult or Pediatric Oncology
- Pediatric Infectious Disease
- Pediatric Cystic Fibrosis
- OBGYN
Elective Rotational Experiences:
- Academia
- Antithrombotic Stewardship
- Cardiology
- Emergency Medicine
- Infectious Diseases
- Neurology
- Precepting
- Solid Organ Transplant
- Stroke and Hematology
- Trauma
May repeat any of the required or selective required learning experiences
Longitudinal Learning Experiences:
- Administrator-On-Call
- Code Response On-Call
- Continuing Education
- Formulary Management
- Hospital Pharmacy Practice (Staffing)
- Medication Use Evaluation
- Practice-Related Research Project
- Teaching and Precepting
- WVU Teaching Certificate (optional)
Pharmacy Practice Component:
- PGY1 Pharmacy Residents practice every third weekend (two 8-hour shifts) and one weeknight evening shift per two-week pay period (8-hour shift).
- All residents work one summer holiday (Memorial Day, Labor Day) and one winter holiday (Thanksgiving, Christmas, New Year’s).
- Residents may opt to work additional pharmacist shifts and will be compensated at the standard pharmacist rate, including shift differential. Residents are reminded that the primary objective of the residency year relates to the residency program objectives, and other activities should not hinder the achievement of these objectives.
PGY1 Residency Program Director
Matt Whiteman, PharmD, BCPPS graduated from West Virginia University School of Pharmacy in 2019. He completed a PGY1 Acute Care Pharmacy Residency at Mission Hospital in Asheville, NC and a PGY2 in Pediatrics at UNC Health in Chapel Hill, NC. After graduating from residency, Dr. Whiteman was the pediatric infectious disease & antimicrobial stewardship pharmacist here at WVU Medicine Children’s Hospital prior to transitioning into this role. He is a member of the Pediatric Infectious Disease Society, Pediatric Pharmacy Association, American Society of Health-System Pharmacists, and Kappa Psi Pharmaceutical Fraternity.